Operating Cash Flow (Statement)

$2.49B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$2.49Bperiod endingJun 30, 2026

ABT Quarterly Cash from Operations ($217.50M → $2.49B)

Quarterly operating cash flow (statement)

High-resolution chart · PNG

ABT operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Operating Cash Flow (Statement) — Quarterly (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	1,591,514,000
Mar 31, 2001	-96,434,000
Dec 31, 2000	774,183,000
Sep 30, 2000	677,881,000
Jun 30, 2000	1,267,589,000
Mar 31, 2000	379,965,000
Dec 31, 1999	404,246,000
Sep 30, 1999	921,098,000
Jun 30, 1999	766,789,000
Mar 31, 1999	845,388,000
Dec 31, 1998	464,788,000
Sep 30, 1998	570,470,000
Jun 30, 1998	816,260,000
Mar 31, 1998	881,383,000
Dec 31, 1997	618,556,000
Sep 30, 1997	646,305,000
Jun 30, 1997	579,280,000
Mar 31, 1997	784,626,000
Dec 31, 1996	570,518,000
Sep 30, 1996	632,534,000
Jun 30, 1996	494,844,000
Mar 31, 1996	684,166,000
Dec 31, 1995	411,182,000
Sep 30, 1995	519,184,000
Jun 30, 1995	526,886,000
Mar 31, 1995	508,329,000
Dec 31, 1994	591,694,000
Sep 30, 1994	600,455,000
Jun 30, 1994	473,143,000
Mar 31, 1994	546,845,000
Dec 31, 1993	472,109,000
Sep 30, 1993	572,700,000
Jun 30, 1993	366,100,000
Mar 31, 1993	436,000,000
Dec 31, 1992	508,400,000
Sep 30, 1992	267,500,000
Jun 30, 1992	344,600,000
Mar 31, 1992	268,300,000
Dec 31, 1991	414,200,000
Sep 30, 1991	408,300,000
Jun 30, 1991	385,300,000
Mar 31, 1991	245,400,000
Dec 31, 1990	374,900,000
Sep 30, 1990	360,500,000
Jun 30, 1990	248,000,000
Mar 31, 1990	217,500,000